Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7767]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
BRAF/MEK inhibition as adjuvant treatment in melanoma
Dr Jessica Hassel - Heidelberg University Hospital, Heidelberg, Germany
BRAF/MEK inhibition as adjuvant treatment in melanoma ( Dr Jessica Hassel - Heidelberg University Hospital, Heidelberg, Germany )
22 Nov 2018
EADO 2018: Melanoma roundup with a view to patients
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
EADO 2018: Melanoma roundup with a view to patients ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
22 Nov 2018
The changing landscape of melanoma treatment
Dr Eva Muñoz-Couselo - University Hospital Vall d'Hebron
The changing landscape of melanoma treatment ( Dr Eva Muñoz-Couselo - University Hospital Vall d'Hebron )
22 Nov 2018
Immunosenescence and autoantibodies in ageing patients
Dr Capucine Baldini - Centre Oscar Lambret, Lille, France
Immunosenescence and autoantibodies in ageing patients ( Dr Capucine Baldini - Centre Oscar Lambret, Lille, France )
22 Nov 2018
The emerging era of no-completion lymph node dissection
Dr Daniel Coit - Memorial Sloan Kettering Cancer Centre, New York, USA
The emerging era of no-completion lymph node dissection ( Dr Daniel Coit - Memorial Sloan Kettering Cancer Centre, New York, USA )
20 Nov 2018
Do we still need surgery in advanced melanoma?
Prof John Thompson - University of Sydney, Sydney, Australia
Do we still need surgery in advanced melanoma? ( Prof John Thompson - University of Sydney, Sydney, Australia )
20 Nov 2018
Breast cancer highlights from ESMO 2018
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Breast cancer highlights from ESMO 2018 ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
12 Nov 2018
Editor’s Choice for October 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for October 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
1 Nov 2018
The IMpower-132 trial for non small cell lung cancer
Dr Vassiliki Papadimitrakopoulou - University of Texas MD Anderson Cancer...
The IMpower-132 trial for non small cell lung cancer ( Dr Vassiliki Papadimitrakopoulou - University of Texas MD Anderson Cancer Center, Houston, US )
29 Oct 2018
ILLUMINATE 301: ipilimumab versus IMO-2125 combined with ipilimumab in anti PD...
Prof Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy
ILLUMINATE 301: ipilimumab versus IMO-2125 combined with ipilimumab in anti PD 1 refractory melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy )
29 Oct 2018
Keynote lecture: Mutation signatures and targeting the DNA damage response
Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK
Keynote lecture: Mutation signatures and targeting the DNA damage response ( Prof Thomas Helleday - Sheffield Cancer Centre, Sheffield, UK )
29 Oct 2018
Dosing regiment in the combination of ipilimumab and nivolumab in stage III...
Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands
Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma ( Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands )
29 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation